Raras
Buscar doenças, sintomas, genes...
Epilepsia noturna do lobo frontal autossômica dominante
ORPHA:98784CID-10 · G40.0CID-11 · 8A61.4YPCDT · SUSDOENÇA RARA

Um tipo de epilepsia caracterizado por movimentos musculares involuntários e descontrolados que acontecem de forma intermitente durante o sono. Os grupos dessas crises de movimento que ocorrem à noite são geralmente muito parecidos entre si e curtos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um tipo de epilepsia caracterizado por movimentos musculares involuntários e descontrolados que acontecem de forma intermitente durante o sono. Os grupos dessas crises de movimento que ocorrem à noite são geralmente muito parecidos entre si e curtos.

Publicações científicas
145 artigos
Último publicado: 2026 Apr 14

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Casos conhecidos
100
pacientes catalogados
Início
Adolescent
+ adult, childhood
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G40.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
17 sintomas
💪
Músculos
2 sintomas
👁️
Olhos
1 sintomas
🫘
Rins
1 sintomas

+ 12 sintomas em outras categorias

Características mais comuns

90%prev.
Convulsões noturnas
Muito frequente (99-80%)
55%prev.
Distonia paroxística
Frequente (79-30%)
55%prev.
Maneirismos repetitivos anormais
Frequente (79-30%)
55%prev.
Movimentos involuntários
Frequente (79-30%)
17%prev.
Comprometimento cognitivo
Ocasional (29-5%)
17%prev.
Confusão ao despertar
33sintomas
Muito frequente (1)
Frequente (3)
Ocasional (12)
Muito raro (6)
Sem dados (11)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 33 características clínicas mais associadas, ordenadas por frequência.

Convulsões noturnasNocturnal seizures
Muito frequente (99-80%)90%
Distonia paroxísticaParoxysmal dystonia
Frequente (79-30%)55%
Maneirismos repetitivos anormaisAbnormal repetitive mannerisms
Frequente (79-30%)55%
Movimentos involuntáriosInvoluntary movements
Frequente (79-30%)55%
Comprometimento cognitivoCognitive impairment
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico145PubMed
Últimos 10 anos142publicações
Pico202123 papers
Linha do tempo
2026Hoje · 2026🧪 2021Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

7 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

KCNT1Potassium channel subfamily T member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Sodium-activated K(+) channel (PubMed:37494189). Acts as an important mediator of neuronal membrane excitability (PubMed:37494189). Contributes to the delayed outward currents (By similarity). Regulates neuronal bursting in sensory neurons (By similarity). Contributes to synaptic development and plasticity (By similarity)

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 14

A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
94.7 TPM
Cérebro - Hemisfério cerebelar
80.1 TPM
Córtex cerebral
44.1 TPM
Brain Frontal Cortex BA9
30.4 TPM
Baço
20.2 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 14autosomal dominant nocturnal frontal lobe epilepsy 5malignant migrating partial seizures of infancyautosomal dominant nocturnal frontal lobe epilepsy
HGNC:18865UniProt:Q5JUK3
CHRNA4Neuronal acetylcholine receptor subunit alpha-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti

LOCALIZAÇÃO

Synaptic cell membraneCell membrane

VIAS BIOLÓGICAS (3)
Highly calcium permeable nicotinic acetylcholine receptorsHighly sodium permeable postsynaptic acetylcholine nicotinic receptorsHighly calcium permeable postsynaptic nicotinic acetylcholine receptors
MECANISMO DE DOENÇA

Epilepsy, nocturnal frontal lobe, 1

An autosomal dominant focal epilepsy characterized by nocturnal seizures with hyperkinetic automatisms and poorly organized stereotyped movements.

OUTRAS DOENÇAS (3)
autosomal dominant nocturnal frontal lobe epilepsy 1autosomal dominant nocturnal frontal lobe epilepsytobacco addiction, susceptibility to
HGNC:1958UniProt:P43681
CHRNB2Neuronal acetylcholine receptor subunit beta-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti

LOCALIZAÇÃO

Synaptic cell membraneCell membrane

VIAS BIOLÓGICAS (3)
Highly calcium permeable nicotinic acetylcholine receptorsHighly sodium permeable postsynaptic acetylcholine nicotinic receptorsHighly calcium permeable postsynaptic nicotinic acetylcholine receptors
MECANISMO DE DOENÇA

Epilepsy, nocturnal frontal lobe, 3

An autosomal dominant focal epilepsy characterized by nocturnal seizures with hyperkinetic automatisms and poorly organized stereotyped movements.

OUTRAS DOENÇAS (2)
autosomal dominant nocturnal frontal lobe epilepsy 3autosomal dominant nocturnal frontal lobe epilepsy
HGNC:1962UniProt:P17787
CHRNA2Neuronal acetylcholine receptor subunit alpha-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti

LOCALIZAÇÃO

Synaptic cell membraneCell membrane

VIAS BIOLÓGICAS (2)
Highly calcium permeable nicotinic acetylcholine receptorsHighly calcium permeable postsynaptic nicotinic acetylcholine receptors
MECANISMO DE DOENÇA

Epilepsy, nocturnal frontal lobe, 4

An autosomal dominant focal epilepsy characterized by nocturnal seizures associated with fear sensation, tongue movements, and nocturnal wandering, closely resembling nightmares and sleep walking.

OUTRAS DOENÇAS (2)
autosomal dominant nocturnal frontal lobe epilepsy 4autosomal dominant nocturnal frontal lobe epilepsy
HGNC:1956UniProt:Q15822
CABP4Calcium-binding protein 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in normal synaptic function through regulation of Ca(2+) influx and neurotransmitter release in photoreceptor synaptic terminals and in auditory transmission. Modulator of CACNA1D and CACNA1F, suppressing the calcium-dependent inactivation and shifting the activation range to more hyperpolarized voltages (By similarity)

LOCALIZAÇÃO

CytoplasmPresynapse

MECANISMO DE DOENÇA

Cone-rod synaptic disorder, congenital non-progressive

A non-progressive retinal disorder characterized by stable low vision, nystagmus, photophobia, a normal or near-normal fundus appearance, and no night blindness.

OUTRAS DOENÇAS (2)
cone-rod synaptic disorder, congenital nonprogressiveautosomal dominant nocturnal frontal lobe epilepsy
HGNC:1386UniProt:P57796
CRHCorticoliberinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Hormone regulating the release of corticotropin from pituitary gland (By similarity). Induces NLRP6 in intestinal epithelial cells, hence may influence gut microbiota profile (By similarity)

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (3)
G alpha (s) signalling eventsClass B/2 (Secretin family receptors)MECP2 regulates transcription of neuronal ligands
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
12.2 TPM
Brain Anterior cingulate cortex BA24
9.8 TPM
Córtex cerebral
8.3 TPM
Hipotálamo
6.2 TPM
Cérebro - Amígdala
3.5 TPM
OUTRAS DOENÇAS (1)
autosomal dominant nocturnal frontal lobe epilepsy
HGNC:2355UniProt:P06850
DEPDC5GATOR1 complex protein DEPDC5Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the mTORC1 pathway (PubMed:23723238, PubMed:25457612, PubMed:29590090, PubMed:29769719, PubMed:31548394, PubMed:35338845). In response to amino acid depletion, the GATOR1 complex has GTPase activating protein (GAP) activity and strongly increases GTP hydrolysis by RagA/RRAGA (or RagB/RRAGB) within heterodimeric Rag complexes, thereby turning them into their inactive GDP-bound form, releasing mTORC1

LOCALIZAÇÃO

Lysosome membraneCytoplasm, cytosolCytoplasm, perinuclear region

VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
MECANISMO DE DOENÇA

Epilepsy, familial focal, with variable foci 1

An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions in different family members. Many patients have an aura and show automatisms during the seizures, whereas others may have nocturnal seizures. There is often secondary generalization. Some patients show abnormal interictal EEG, and some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. Penetrance of the disorder is incomplete.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
16.3 TPM
Testículo
13.5 TPM
Linfócitos
10.8 TPM
Baço
10.6 TPM
Cervix Ectocervix
10.5 TPM
OUTRAS DOENÇAS (5)
epilepsy, familial focal, with variable foci 1developmental and epileptic encephalopathy 111familial focal epilepsy with variable fociundetermined early-onset epileptic encephalopathy
HGNC:18423UniProt:O75140

Variantes genéticas (ClinVar)

872 variantes patogênicas registradas no ClinVar.

🧬 DEPDC5: NM_001242896.3(DEPDC5):c.3021+1G>T ()
🧬 DEPDC5: NM_001242896.3(DEPDC5):c.789_790del (p.Glu265fs) ()
🧬 DEPDC5: NM_001242896.3(DEPDC5):c.4745_4746del (p.Asn1582fs) ()
🧬 DEPDC5: NM_001242896.3(DEPDC5):c.3842del (p.Ala1281fs) ()
🧬 DEPDC5: NM_001242896.3(DEPDC5):c.2458C>T (p.Gln820Ter) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 153 variantes classificadas pelo ClinVar.

23
8
122
Patogênica (15.0%)
VUS (5.2%)
Benigna (79.7%)
VARIANTES MAIS SIGNIFICATIVAS
PRIMA1: NC_000014.8:g.(?_94245502)_(94245677_?)del [Pathogenic]
PRIMA1: NC_000014.8:g.(?_94187790)_(94254064_?)del [Pathogenic]
PRIMA1: NM_178013.4(PRIMA1):c.80G>A (p.Trp27Ter) [Pathogenic]
PRIMA1: NM_178013.4(PRIMA1):c.59A>T (p.His20Leu) [Uncertain significance]
PRIMA1: NM_178013.4(PRIMA1):c.237C>T (p.Asn79=) [Likely benign]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Epilepsia noturna do lobo frontal autossômica dominante

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
145 papers (10 anos)
#1

Crisis-like Seizure Exacerbations in NPRL3-related Epilepsy: Phenotypic Features and Treatment Outcomes.

Neuropediatrics2026 Feb

NPRL3 (nitrogen permease regulator-like 3) variants are associated with focal epilepsy syndromes, including sleep-related hypermotor epilepsy (SHE) and familial focal epilepsy with variable foci (FFEVF), with or without focal cortical dysplasia (FCD). The NPRL3 gene encodes a protein that forms the GATOR1 complex, which regulates the mTOR signaling pathway.To characterize the epilepsy phenotype associated with NPRL3, assess treatment strategies, and evaluate patient prognosis.We conducted a multicenter, retrospective study using an online questionnaire to collect clinical data on seizure onset, crisis-like seizure exacerbations, MRI findings, neuropsychological assessment, treatment, and genetic variants. Variants were classified per ACMG guidelines. The study was part of the Network for Therapy in Rare Epilepsies (NETRE).Data from 37 patients with NPRL3-associated epilepsy were analyzed. Mean age at seizure onset was 3.7 years (median with interquartile range [IQR] 1.3-4.9). Over 1 to 45 years of follow-up (mean 13.6, IQR 5.4-18), 21/37 (57%) experienced crisis-like seizure exacerbations. MRI abnormalities were present in 10/36 (28%) cases: 8 FCD, 1 hippocampal sclerosis, and 1 hippocampal asymmetry. Persistent focal epileptiform discharges were present on serial EEGs in 20/37 patients (54%). Highest drug response rates were seen with lacosamide, followed by clobazam, carbamazepine/oxcarbazepine, and lamotrigine. Epilepsy surgery (n = 8) led to seizure freedom in four and significant reduction in one case.Crisis-like seizure exacerbations were common in NPRL3-associated epilepsy. Sodium channel blockers showed notable efficacy. Epilepsy surgery was beneficial even in MRI-negative cases. No distinct genotype-phenotype correlation was identified.

#2

Unstable slow oscillations couple with epileptogenic fast-rhythm bistability in sleep-related epilepsy: A stereoelectroencephalographic study.

Epilepsia2026 Mar 10

Although slow waves in δ (.5-4 Hz) characterize non-rapid eye movement (NREM) sleep, in patients with sleep-related epilepsy, seizures most frequently emerge during NREM stage 2, known to be promoted by δ-band instability. Meanwhile, the epileptogenic zone (EZ) shows localized bistability in β-γ-band (15-200 Hz) neuronal oscillations, indicating a catastrophic shift toward seizure. We aim to clarify the mechanistic link between δ-band synchrony and β-γ-band bistability in epilepsy. We studied a cohort of 14 patients with sleep hypermotor epilepsy (22.3 ± 10.8 years old, seven males). Seven- to 9-h stereoelectroencephalographic sleep recordings were segmented into 10-min uninterrupted, interictal N2 and N3 epochs, and phase synchrony, phase-amplitude coupling (PAC), and bistability were assessed. Canonical correlation was examined to answer whether PAC links δ phase to β-γ bistability. Compared to non-EZ, the EZ exhibited larger 15-200-Hz bistability along with stronger 2-8-Hz and 15-100-Hz synchrony throughout N2 and N3. Compared to N3, N2 showed stronger PAC between 2-30-Hz phases in the non-EZ and 5-150-Hz amplitudes in the EZ. Canonical correlations between δ phase modulated PAC, and both bistability and synchrony were identified during N2 (r = .86 and .82) and N3 (r = .84 and .80), with the strongest contributors being 2-4-Hz synchrony and bistability in 2-4-Hz and 15-200-Hz bands. Correlations between interictal spikes and canonical covariates of bistability and PAC (r2 = .62 for N2 and .56 for N3) validated their relevance to epileptogenicity. δ-Band synchrony and β-γ-band bistability are not isolated epileptogenic mechanisms but likely act synergistically, playing a pivotal role in seizure generation through the coupling of δ phases and β-γ amplitudes across large networks, with significant contributions from nonepileptogenic tissues.

#3

Automated video-based differentiation of sleep-related hypermotor epilepsy and parasomnia episodes.

NPJ digital medicine2026 Jan 08

Distinguishing epileptic seizures from parasomnias is challenging due to overlapping motor features. This study evaluated a SlowFast deep learning model using video recordings of 167 individuals to classify Sleep-Related Hypermotor Epilepsy, Disorders of Arousal, and REM Sleep Behavior Disorder. The model achieved a mean accuracy of 83.3% across three data splits. This work represents an initial step toward developing automated tools to support clinicians in assessing sleep-related motor events.

#4

Nicotine as target-therapy in Sleep-Related Hypermotor Epilepsy due to nAChR genes mutation: case report and systematic review of literature.

Sleep medicine2026 Jan

Ten to fifteen per cent of Sleep-Related-Hypermotor-Epilepsy (SHE) has genetic origin, mainly related to pathogenic variants of genes coding for nicotinic cholinergic receptor (nAChR) system. We reported a subject with SHE due to CHRNA4 mutation, successfully treated with Nicotine. We also provided a systematic review on the use of Nicotine as an anti-seizure-medication and sleep regulator in SHE due to nAChR genes mutation. We conducted a comprehensive search on PubMed/MEDLINE, SCOPUS and EMBASE in accordance with PRISMA guidelines, using the keywords: "epilepsy" and "Nicotine". We included studies with at least one subject with SHE due to nAChR genes mutation treated with Nicotine (tobacco, snuff or patch). The aim was to evaluate the effectiveness and safety of Nicotine medication. Our patient benefited from treatment with nicotine patches, reporting reduction in seizure frequency and improved sleep quality as confirmed by polysomnographic and actigraphic monitoring. In our systematic review we identified 31 patients with nAChR-related-SHE treated with Nicotine. Seventy-nine percent of subjects had drug-resistant epilepsy when Nicotine trial was started. Ninety-four percent of subjects achieved a significant decrease in seizure frequency and 47 % of patients reached a seizure freedom condition. In no patient the seizure frequency increased. Side effects occurred in 23 % of patch-treated subjects; in 14 %, they were not controlled by dose reduction. The most frequently used patch dosage and the one with the lowest incidence of side effects was 7mg/24 h. Nicotine patch seems effective and relatively safe in patients with SHE due to nAChR gene mutation. Randomized case-control studies are needed to better assess its therapeutic role.

#5

Novel NPRL3 variant associated with sleep-related hypermotor epilepsy: a case report and educational review.

Frontiers in neuroscience2025

Sleep-related hypermotor epilepsy (SHE) is a rare epileptic syndrome characterized by nocturnal seizures that predominantly arise during sleep, featuring complex motor behaviors. Pathogenic variants in the nitrogen permease regulator-like 3 (NPRL3) gene and other regulators of the mTOR pathway have been linked to diverse epilepsy phenotypes, including SHE. SHE is challenging to diagnose due to its diverse presentations, overlap with non-epileptic sleep disorders, and semiological similarities to functional/dissociative seizures (FDS). We present the case of a 61-year-old woman with a lifelong history of nocturnal paroxysmal events and focal epilepsy. She experienced stereotyped nocturnal episodes of focal motor seizures with retained consciousness, characterized by hyperkinetic activity and asymmetric posturing. Despite multiple antiseizure medications (ASMs), only carbamazepine (CBZ) provided long-term seizure freedom. Genetic testing revealed a novel heterozygous mutation in the NPRL3 gene. This case highlights the diagnostic challenges of SHE and the importance of genetic testing in drug-resistant epilepsy. The identified NPRL3 mutation shows the genetic complexity of SHE and its implications for treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC81 artigos no totalmostrando 141

2026

Unstable slow oscillations couple with epileptogenic fast-rhythm bistability in sleep-related epilepsy: A stereoelectroencephalographic study.

Epilepsia
2025

Novel NPRL3 variant associated with sleep-related hypermotor epilepsy: a case report and educational review.

Frontiers in neuroscience
2026

Automated video-based differentiation of sleep-related hypermotor epilepsy and parasomnia episodes.

NPJ digital medicine
2026

Crisis-like Seizure Exacerbations in NPRL3-related Epilepsy: Phenotypic Features and Treatment Outcomes.

Neuropediatrics
2026

Nicotine as target-therapy in Sleep-Related Hypermotor Epilepsy due to nAChR genes mutation: case report and systematic review of literature.

Sleep medicine
2025

Emerging Role of Tripartite Synaptic Transmission in the Pathomechanism of Autosomal-Dominant Sleep-Related Hypermotor Epilepsy.

International journal of molecular sciences
2025

Clinical and EEG characteristics of sleep-related hypermotor epilepsy in children.

Epilepsy research
2025

Identification of New KCNT1-Epilepsy Drugs by In Silico, Cell, and Drosophila Modeling.

Annals of neurology
2025

When sleep turns violent: coexisting sleep-related hypermotor epilepsy and somnambulism documented by polysomnography.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2025

Reliability and diagnostic accuracy of home video recording in differentiating sleep-related hypermotor epilepsy from disorders of arousal.

Epilepsia
2025

The role of genetic testing in evaluating surgical outcomes for pediatric focal cortical dysplasia associated with NPRL3 variant.

Epilepsy &amp; behavior reports
2025

Novel ADGRV1 pathogenic variant associated to sleep-related hypermotor epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2025

Disorders of arousal and sleep-related hypermotor epilepsy are interrelated. Some new viewpoints.

Seizure
2025

Sleep-related epilepsy through the lens of stereo-EEG: Clinical and research update.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2025

Subcortical Circuits Among Pedunculopontine Nucleus, Thalamus and Basal Ganglia Play Important Roles in Paroxysmal Arousal in Genetic Rat Models of Autosomal Dominant Sleep-Related Hypermotor Epilepsy.

International journal of molecular sciences
2025

Theta bursts in patients with sleep-related hypermotor epilepsy: potential marker of impaired inhibitory control and its mitigation through musical stimulation.

Cerebral cortex (New York, N.Y. : 1991)
2025

Rapid eye movement sleep without atonia in patients with sleep-related fronto-temporal epilepsy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Pearls & Oy-sters: ADCY5-Related Dyskinesia: From a Longstanding Misdiagnosis of Drug-Resistant Epilepsy.

Neurology
2025

Insights from stereoelectroencephalography in KCNT1-related focal epilepsy suggest a multifocal and migrating epileptogenic network.

Epilepsia
2025

Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease.

BMJ case reports
2025

Tonic-clonic seizures induce hypersomnia and suppress rapid eye movement sleep in mouse models of epilepsy.

Sleep advances : a journal of the Sleep Research Society
2025

Sleep-related hypermotor epilepsy-No longer controversial.

Epilepsia
2025

Durable suppression of seizures in a preclinical model of KCNT1 genetic epilepsy with divalent small interfering RNA.

Epilepsia
2025

Brain changes in sleep-related hypermotor epilepsy observed from wakefulness and N2 sleep: A matched case-control study.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2025

PAK3 pathogenic variant associated with sleep-related hypermotor epilepsy in a family with parental mosaicism.

Epilepsia open
2024

Sleep-related hypermotor seizures originating from the occipital lobe.

Epileptic disorders : international epilepsy journal with videotape
2024

Pearls & Oy-sters: Exquisite Response of Sleep-Related Hypermotor Epilepsy to a Nicotine Patch.

Neurology
2024

Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review.

Epilepsia open
2024

Nocturnal paroxysmal dystonia to sleep-related hypermotor epilepsy: A critical review.

Epilepsia
2024

Nonsense mutation in DEPDC5 gene in a patient with carbamazepine-responsive focal epilepsy.

Epilepsy &amp; behavior reports
2024

Pathogenic genes implicated in sleep-related hypermotor epilepsy: a research progress update.

Frontiers in neurology
2024

Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy.

Frontiers in cellular neuroscience
2024

Epileptic seizure or parasomnia? From knowledge to recognition. Sleep-related hypermotor epilepsy.

Anales de pediatria
2024

Mice harboring the T316N variant in the GABAAR γ2 subunit exhibit sleep-related hypermotor epilepsy phenotypes and hypersynchronization in the thalamocortical pathway.

Experimental neurology
2024

Ictal Bradycardia and Asystole in Sleep-Related Hypermotor Epilepsy: A Study of 200 Patients.

Journal of clinical medicine
2024

[Recent studies about the underlying cerebral mechanism of the fearfull arousals from slow wave sleep].

Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata
2024

Age-Dependent Activation of Purinergic Transmission Contributes to the Development of Epileptogenesis in ADSHE Model Rats.

Biomolecules
2024

[Hitting and yelling during sleep: diagnosis and implications of REM sleep behavior disorder].

Nederlands tijdschrift voor geneeskunde
2024

Age-Dependent Activation of Pannexin1 Function Contributes to the Development of Epileptogenesis in Autosomal Dominant Sleep-related Hypermotor Epilepsy Model Rats.

International journal of molecular sciences
2024

Fearful arousals in sleep terrors and sleep-related hypermotor epileptic seizures may involve the salience network and the acute stress response of Cannon and Selye.

Epilepsy &amp; behavior reports
2024

Imaging biomarkers of sleep-related hypermotor epilepsy and sudden unexpected death in epilepsy: a review.

Seizure
2023

Case report: A young man with non-rapid eye movement parasomnias in a KCNT1-related epilepsy family.

Frontiers in neurology
2024

Phenotypic and genotypic characterization of NPRL3-related epilepsy: Two case reports and literature review.

Epilepsia open
2024

Clinical phenotype and genotype of NPRL2-related epilepsy: Four cases reports and literature review.

Seizure
2023

Two novel variants of the STXBP1 and CHRNB2 genes identified in a Chinese boy with refractory seizures and developmental delay.

Psychiatric genetics
2023

Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases.

Cells
2023

Refining the electroclinical spectrum of NPRL3-related epilepsy: A novel multiplex family and literature review.

Epilepsia open
2023

Progressive structural damage in sleep-related hypermotor epilepsy.

Journal of neuroscience research
2023

Automatic video analysis and classification of sleep-related hypermotor seizures and disorders of arousal.

Epilepsia
2023

Clinical phenotypic and genotypic characterization of NPRL3-related epilepsy.

Frontiers in neurology
2023

Epilepsy surgery outcomes in patients with GATOR1 gene complex variants: Report of new cases and review of literature.

Seizure
2023

Nicotinic acetylcholine receptors and epilepsy.

Pharmacological research
2023

Neuropsychological and Behavioral Profile in Sleep-Related Hypermotor Epilepsy (SHE) and Disorders of Arousal (DOA): A Multimodal Analysis.

Journal of clinical medicine
2023

Violent and Complex Behaviors and Non-Restorative Sleep Are the Main Features of Disorders of Arousal in Adulthood: Real Picture or a More Severe Phenotype?

Journal of clinical medicine
2023

Interictal and subclinical ictal discharges emerging from tonic REM sleep in sleep-related hypermotor epilepsy.

Sleep medicine
2023

Abnormal brain functional network dynamics in sleep-related hypermotor epilepsy.

CNS neuroscience &amp; therapeutics
2022

Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy.

Expert opinion on drug discovery
2022

What respiratory physicians should know about parasomnias.

Breathe (Sheffield, England)
2022

Incidence of Aicardi-Goutières syndrome and KCNT1-related epilepsy in Denmark.

Molecular genetics and metabolism reports
2022

Exome Sequencing in an ADSHE Family: VUS Identification and Limits.

International journal of environmental research and public health
2022

Autosomal dominant sleep-related hypermotor epilepsy associated with a novel mutation of KCNT1.

Translational neuroscience
2022

Psychogenic non-epileptic seizures arising almost exclusively from sleep.

Seizure
2022

The β2V287L nicotinic subunit linked to sleep-related epilepsy differently affects fast-spiking and regular spiking somatostatin-expressing neurons in murine prefrontal cortex.

Progress in neurobiology
2022

Rare variants in GABRG2 associated with sleep-related hypermotor epilepsy.

Journal of neurology
2022

Genetic Epilepsy Syndromes.

Continuum (Minneapolis, Minn.)
2022

KNa1.1 gain-of-function preferentially dampens excitability of murine parvalbumin-positive interneurons.

Neurobiology of disease
2022

High frequency oscillations play important roles in development of epileptogenesis/ictogenesis via activation of astroglial signallings.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2022

Sleep-related hypermotor epilepsy with genetic diagnosis: description of a case series in a tertiary referral hospital.

Journal of central nervous system disease
2022

Autosomal dominant sleep-related hypermotor epilepsy caused by a previously unreported CHRNA4 variant.

European journal of medical genetics
2022

Disorders of arousal and sleep-related hypermotor epilepsy - overview and challenges night is a battlefield of sleep and arousal promoting forces.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Sleep-related hypermotor epilepsy in a patient with mucopolysaccharidosis type III.

Sleep science (Sao Paulo, Brazil)
2021

Phenotypic and Genotypic Characterization of NPRL2-Related Epilepsy: Two Case Reports and Literature Review.

Frontiers in neurology
2021

Sleep-Related Hypermotor Epilepsy: Etiology, Electro-Clinical Features, and Therapeutic Strategies.

Nature and science of sleep
2021

Precision treatment with nicotine in autosomal dominant sleep-related hypermotor epilepsy (ADSHE): An observational study of clinical outcome and serum cotinine levels in 17 patients.

Epilepsy research
2021

A 16-Year-Old Male With Frequent Nocturnal Events During Slow Wave Sleep on a Polysomnogram.

Cureus
2022

The phenotypic spectrum of KCNT1: a new family with variable epilepsy syndromes including mild focal epilepsy.

Journal of neurology
2021

Nicotine Patch Improved Autosomal Dominant Sleep-Related Hypermotor Epilepsy.

Pediatric neurology
2021

Seizure worsening in pregnancy in women with sleep-related hypermotor epilepsy (SHE): A historical cohort study.

Seizure
2021

REM sleep behavior disorder: Mimics and variants.

Sleep medicine reviews
2021

Gastroesophageal reflux-related Non-Rapid Eye Movement parasomnia mimicking sleep-related hypermotor epilepsy.

Sleep medicine
2021

Metabolic alterations of the dorsolateral prefrontal cortex in sleep-related hypermotor epilepsy: A proton magnetic resonance spectroscopy study.

Journal of neuroscience research
2021

KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.

Brain : a journal of neurology
2021

Sleep and Epilepsy, Clinical Spectrum and Updated Review.

Sleep medicine clinics
2021

Treatment of pharmacoresistant sleep-related hypermotor epilepsy (SHE) with the selective AMPA receptor antagonist perampanel.

Sleep medicine
2021

Sleep-related hypermotor epilepsy and non-rapid eye movement parasomnias: Differences in the periodic and aperiodic component of the electroencephalographic power spectra.

Journal of sleep research
2022

Can rodent models elucidate the pathomechanisms of genetic epilepsy?

British journal of pharmacology
2021

Sleep-related hypermotor epilepsy associated mutations uncover important kinetic roles of α4β2- nicotinic acetylcholine receptor intracellular structures.

PloS one
2021

The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units.

Sleep medicine
2021

TSC1 as a Novel Gene for Sleep-Related Hypermotor Epilepsy: A Child with a Mild Phenotype of Tuberous Sclerosis.

Neuropediatrics
2021

Bidirectional relationships of sleep and epilepsy in adults with epilepsy.

Epilepsy &amp; behavior : E&amp;B
2021

Sleep-Related Hypermotor Epilepsy vs Disorders of Arousal in Adults: A Step-Wise Approach to Diagnosis.

Chest
2020

Commonalities and Differences in NREM Parasomnias and Sleep-Related Epilepsy: Is There a Continuum Between the Two Conditions?

Frontiers in neurology
2021

Utility of the Frontal Lobe Epilepsy Parasomnia Scale in Evaluation of Children With Nocturnal Events.

The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses
2021

Nicotine: A Targeted Therapy for Epilepsy Due to nAChR Gene Variants.

Journal of child neurology
2020

Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology.

Brain sciences
2021

Abnormal blood oxygen level-dependent fluctuations and remote connectivity in sleep-related hypermotor epilepsy.

Acta neurologica Scandinavica
2020

Age-Dependent and Sleep/Seizure-Induced Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy.

International journal of molecular sciences
2021

Utilising Automated Electrophysiological Platforms in Epilepsy Research.

Methods in molecular biology (Clifton, N.J.)
2020

[Advances in sleep-related hypermotor epilepsy].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2020

Standard procedures for the diagnostic pathway of sleep-related epilepsies and comorbid sleep disorders: A European Academy of Neurology, European Sleep Research Society and International League against Epilepsy-Europe consensus review.

Journal of sleep research
2020

Seizures with paroxysmal arousals in sleep-related hypermotor epilepsy (SHE): Dissecting epilepsy from NREM parasomnias.

Epilepsia
2020

Parasomnias, sleep-related movement disorders and physiological sleep variants in focal epilepsy: A polysomnographic study.

Seizure
2020

The potential role of micro-RNA-211 in the pathogenesis of sleep-related hypermotor epilepsy.

Medical hypotheses
2020

Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2020

Upregulated and Hyperactivated Thalamic Connexin 43 Plays Important Roles in Pathomechanisms of Cognitive Impairment and Seizure of Autosomal Dominant Sleep-Related Hypermotor Epilepsy with S284L-Mutant α4 Subunit of Nicotinic ACh Receptor.

Pharmaceuticals (Basel, Switzerland)
2020

Upregulated Connexin 43 Induced by Loss-of-Functional S284L-Mutant α4 Subunit of Nicotinic ACh Receptor Contributes to Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy.

Pharmaceuticals (Basel, Switzerland)
2020

Pathomechanism of nocturnal paroxysmal dystonia in autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2020

Remarkable effect of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-related hypermotor epilepsy.

Epilepsy &amp; behavior : E&amp;B
2020

Two mutations in the nicotinic acetylcholine receptor subunit A4 (CHRNA4) in a family with autosomal dominant sleep-related hypermotor epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2020

Therapy in Sleep-Related Hypermotor Epilepsy (SHE).

Current treatment options in neurology
2020

Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor.

British journal of pharmacology
2020

Sleep-related hypermotor epilepsy (SHE): Contribution of known genes in 103 patients.

Seizure
2019

Sleep-related hypermotor epilepsy: A prediction cohort study on sleep/awake patterns of seizures.

Epilepsia
2019

Polysomnographic features differentiating disorder of arousals from sleep-related hypermotor epilepsy.

Sleep
2019

Insights into sleep-related hyper-motor epilepsy: an Egyptian case series.

Neurological research
2019

Migrating focal seizures in Autosomal Dominant Sleep-related Hypermotor Epilepsy with KCNT1 mutation.

Seizure
2019

Clinical features of sleep-related hypermotor epilepsy in relation to the seizure-onset zone: A review of 135 surgically treated cases.

Epilepsia
2019

Mild malformations of cortical development in sleep-related hypermotor epilepsy due to KCNT1 mutations.

Annals of clinical and translational neurology
2019

CHRNA2 and Nocturnal Frontal Lobe Epilepsy: Identification and Characterization of a Novel Loss of Function Mutation.

Frontiers in molecular neuroscience
2018

Sleep-related hypermotor epilepsy and peri-ictal hypotension in a patient with syntaxin-1B mutation.

Epileptic disorders : international epilepsy journal with videotape
2018

Sleep-related hypermotor epilepsy: prevalence, impact and management strategies.

Nature and science of sleep
2018

Sleep Related Epilepsy and Pharmacotherapy: An Insight.

Frontiers in pharmacology
2018

Seizure duration and latency of hypermotor manifestations distinguish frontal from extrafrontal onset in sleep-related hypermotor epilepsy.

Epilepsia
2018

Profile of neuropsychological impairment in Sleep-related Hypermotor Epilepsy.

Sleep medicine
2018

Sleep-related motor and behavioral disorders: Recent advances and new entities.

Movement disorders : official journal of the Movement Disorder Society
2018

Brain functional connectivity in sleep-related hypermotor epilepsy.

NeuroImage. Clinical
2018

A case series of lacosamide as adjunctive therapy in refractory sleep-related hypermotor epilepsy (previously nocturnal frontal lobe epilepsy).

Journal of sleep research
2018

Acquired Sleep-Related Hypermotor Epilepsy with Disrupted White Matter Tracts Assessed by Multishell Diffusion Magnetic Resonance Imaging.

Frontiers in neurology
2017

Obstructive Sleep Apnea Presenting as Non-epileptic Spells: A Unique Combination.

Cureus
2017

Sporadic Nocturnal Frontal Lobe Epilepsy--Report on Two Cases and Review of the First Taiwanese Series of 10 Cases.

Acta neurologica Taiwanica
2020

Sleep-related hypermotor epilepsy in a patient with mild Crouzon syndrome.

Acta neurologica Belgica
2017

Actigraphy: a useful tool to monitor sleep-related hypermotor seizures.

Sleep medicine
2018

Sleep-related hypermotor epilepsy activated by rapid eye movement sleep.

Epileptic disorders : international epilepsy journal with videotape
2017

A stereo EEG study in a patient with sleep-related hypermotor epilepsy due to DEPDC5 mutation.

Seizure
2017

Proton MR Spectroscopy in Patients With Sleep-Related Hypermotor Epilepsy (SHE): Evidence of Altered Cingulate Cortex Metabolism.

Sleep
2017

When sleep-related hypermotor epilepsy (SHE) met Charles Darwin and Francis Galton.

Neurology
2017

Prevalence of Sleep-Related Hypermotor Epilepsy-Formerly Named Nocturnal Frontal Lobe Epilepsy-in the Adult Population of the Emilia-Romagna Region, Italy.

Sleep
2017

From nocturnal frontal lobe epilepsy to Sleep-Related Hypermotor Epilepsy: A 35-year diagnostic challenge.

Seizure
2017

Incidence of sudden unexpected death in epilepsy in sleep-related hypermotor epilepsy, formerly named nocturnal frontal lobe epilepsy.

Sleep medicine
2017

Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort.

Neurology
2016

Definition and diagnostic criteria of sleep-related hypermotor epilepsy.

Neurology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Epilepsia noturna do lobo frontal autossômica dominante.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Epilepsia noturna do lobo frontal autossômica dominante

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Crisis-like Seizure Exacerbations in NPRL3-related Epilepsy: Phenotypic Features and Treatment Outcomes.
    Neuropediatrics· 2026· PMID 41260400mais citado
  2. Unstable slow oscillations couple with epileptogenic fast-rhythm bistability in sleep-related epilepsy: A stereoelectroencephalographic study.
    Epilepsia· 2026· PMID 41804706mais citado
  3. Automated video-based differentiation of sleep-related hypermotor epilepsy and parasomnia episodes.
    NPJ digital medicine· 2026· PMID 41507468mais citado
  4. Nicotine as target-therapy in Sleep-Related Hypermotor Epilepsy due to nAChR genes mutation: case report and systematic review of literature.
    Sleep medicine· 2026· PMID 41192108mais citado
  5. Novel NPRL3 variant associated with sleep-related hypermotor epilepsy: a case report and educational review.
    Frontiers in neuroscience· 2025· PMID 41635699mais citado
  6. Disorders of Arousal and Sleep-Related Hypermotor Epilepsy in adults: a challenging but necessary and critical distinctive diagnosis.
    Eur Neurol· 2026· PMID 41979983recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98784(Orphanet)
  2. MONDO:0000030(MONDO)
  3. Epilepsia(PCDT · Ministério da Saúde)
  4. GARD:11918(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q3589157(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Epilepsia noturna do lobo frontal autossômica dominante

ORPHA:98784 · MONDO:0000030
🇧🇷 Brasil SUS
Geral
Prevalência
Unknown
Casos
100 casos conhecidos
Herança
Autosomal dominant
CID-10
G40.0 · Epilepsia e síndromes epilépticas idiopáticas definidas por sua localização (focal) (parcial) com crises de início focal
CID-11
Início
Adolescent, Adult, Childhood
Prevalência
0.0 (Europe)
MedGen
UMLS
C3696898
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades